PTGS2 and pulmonary arterial hypertension: In conclusion, BMEPCs therapy was effective at attenuating MCT-induced PAH in a rat model and the vasoprotective effects of BMEPCs on pulmonary arteries might be mediated by COX-2/PGI2/cAMP pathway.